1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow HRS-6209 Capsule: new trials by email Literature Review of HRS-6209 Capsule trials Research Report on HRS-6209 Capsule
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer HRS-6208 Capsule, HRS-6209 Capsule, HRS-8080 Tablet - Advanced Unresectable or Metastatic Breast Cancer of Adults | Phase 1 / Phase 2 | Recruiting | Shandong Suncadia Medicine Co., Ltd. | 180 | 2026-03-27 | 2026-04-03 |
Shandong Suncadia Medicine Co., Ltd. (1)
China (1)